To characterize the antibody profile of individuals with COVID-19, we developed a flow cytometry assay based on the full-length SARS-CoV-2 S protein (SFB, S protein flow-based assay), which allows detection of a wider repertoire of antibodies, such as antibodies binding to various domains and conformational epitopes of the S protein. The gene discussed is PROS1; the disease is COVID-19.